Piriformis pyomyositis, a cause of piriformis syndrome—a systematic search and review

Abu Bakar Siddiq, Johannes Jacobus Rasker

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Piriformis pyomyositis is a rare form of purulent skeletal myositis. As previous studies concerning piriformis pyomyositis had lower level of evidence and no systematic review has been published yet, we performed a systematic search to review and describe causes, symptoms, red flags, and available treatment options for piriformis pyomyositis. Using PubMed and PubMed Central databases, we found 21 articles describing 23 cases of piriformis pyomyositis. Based on the retrieved information, alongside acute sciatica like buttock and/or hip pain, high-grade fever, aggressive deep seated gluteal pain, neurological deficit of sciatic nerve distribution, positive straight leg raising test, and raised inflammatory biomarkers (erythrocyte sedimentation rate, ESR, C-reactive protein, CRP) provide clues for diagnosis of piriformis pyomyositis. Some cases were very ill but no death was documented. Staphylococcus aureus was the most common pathogen, but Group A as well as Group β Streptococcus, Salmonella typhi, Proteus mirabilis, Brucella melitensis, and Escherichia coli were also involved in the disorder. To treat the piriformis pyomyositis, broad-spectrum antibiotics were found to be useful; however, sometimes, antibiotic switching was warranted based on blood and tissue aspirate reports. Drainage and/or surgical exploration of the affected piriformis muscle were required in cases where antibiotics appeared ineffective. Piriformis pyomyositis is a rara avis and performing of prospective studies will hardly be feasible.

Original languageEnglish
Pages (from-to)1811-1821
Number of pages11
JournalClinical rheumatology
Volume38
Issue number7
Early online date2 May 2019
DOIs
Publication statusPublished - 1 Jul 2019

Fingerprint

Pyomyositis
Anti-Bacterial Agents
PubMed
Brucella melitensis
Sciatica
Pain
Proteus mirabilis
Salmonella typhi
Buttocks
Myositis
Blood Sedimentation
Sciatic Nerve
Streptococcus
C-Reactive Protein
Staphylococcus aureus
Hip
Drainage
Leg
Fever
Biomarkers

Keywords

  • Myositis
  • Piriformis pyomyositis
  • Piriformis syndrome
  • Staphylococcus aureus
  • Systematic review

Cite this

@article{2c82f761ec1a47cbb65d55282f4b63b1,
title = "Piriformis pyomyositis, a cause of piriformis syndrome—a systematic search and review",
abstract = "Piriformis pyomyositis is a rare form of purulent skeletal myositis. As previous studies concerning piriformis pyomyositis had lower level of evidence and no systematic review has been published yet, we performed a systematic search to review and describe causes, symptoms, red flags, and available treatment options for piriformis pyomyositis. Using PubMed and PubMed Central databases, we found 21 articles describing 23 cases of piriformis pyomyositis. Based on the retrieved information, alongside acute sciatica like buttock and/or hip pain, high-grade fever, aggressive deep seated gluteal pain, neurological deficit of sciatic nerve distribution, positive straight leg raising test, and raised inflammatory biomarkers (erythrocyte sedimentation rate, ESR, C-reactive protein, CRP) provide clues for diagnosis of piriformis pyomyositis. Some cases were very ill but no death was documented. Staphylococcus aureus was the most common pathogen, but Group A as well as Group β Streptococcus, Salmonella typhi, Proteus mirabilis, Brucella melitensis, and Escherichia coli were also involved in the disorder. To treat the piriformis pyomyositis, broad-spectrum antibiotics were found to be useful; however, sometimes, antibiotic switching was warranted based on blood and tissue aspirate reports. Drainage and/or surgical exploration of the affected piriformis muscle were required in cases where antibiotics appeared ineffective. Piriformis pyomyositis is a rara avis and performing of prospective studies will hardly be feasible.",
keywords = "Myositis, Piriformis pyomyositis, Piriformis syndrome, Staphylococcus aureus, Systematic review",
author = "Siddiq, {Abu Bakar} and Rasker, {Johannes Jacobus}",
year = "2019",
month = "7",
day = "1",
doi = "10.1007/s10067-019-04552-y",
language = "English",
volume = "38",
pages = "1811--1821",
journal = "Clinical rheumatology",
issn = "0770-3198",
publisher = "Springer",
number = "7",

}

Piriformis pyomyositis, a cause of piriformis syndrome—a systematic search and review. / Siddiq, Abu Bakar; Rasker, Johannes Jacobus.

In: Clinical rheumatology, Vol. 38, No. 7, 01.07.2019, p. 1811-1821.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Piriformis pyomyositis, a cause of piriformis syndrome—a systematic search and review

AU - Siddiq, Abu Bakar

AU - Rasker, Johannes Jacobus

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Piriformis pyomyositis is a rare form of purulent skeletal myositis. As previous studies concerning piriformis pyomyositis had lower level of evidence and no systematic review has been published yet, we performed a systematic search to review and describe causes, symptoms, red flags, and available treatment options for piriformis pyomyositis. Using PubMed and PubMed Central databases, we found 21 articles describing 23 cases of piriformis pyomyositis. Based on the retrieved information, alongside acute sciatica like buttock and/or hip pain, high-grade fever, aggressive deep seated gluteal pain, neurological deficit of sciatic nerve distribution, positive straight leg raising test, and raised inflammatory biomarkers (erythrocyte sedimentation rate, ESR, C-reactive protein, CRP) provide clues for diagnosis of piriformis pyomyositis. Some cases were very ill but no death was documented. Staphylococcus aureus was the most common pathogen, but Group A as well as Group β Streptococcus, Salmonella typhi, Proteus mirabilis, Brucella melitensis, and Escherichia coli were also involved in the disorder. To treat the piriformis pyomyositis, broad-spectrum antibiotics were found to be useful; however, sometimes, antibiotic switching was warranted based on blood and tissue aspirate reports. Drainage and/or surgical exploration of the affected piriformis muscle were required in cases where antibiotics appeared ineffective. Piriformis pyomyositis is a rara avis and performing of prospective studies will hardly be feasible.

AB - Piriformis pyomyositis is a rare form of purulent skeletal myositis. As previous studies concerning piriformis pyomyositis had lower level of evidence and no systematic review has been published yet, we performed a systematic search to review and describe causes, symptoms, red flags, and available treatment options for piriformis pyomyositis. Using PubMed and PubMed Central databases, we found 21 articles describing 23 cases of piriformis pyomyositis. Based on the retrieved information, alongside acute sciatica like buttock and/or hip pain, high-grade fever, aggressive deep seated gluteal pain, neurological deficit of sciatic nerve distribution, positive straight leg raising test, and raised inflammatory biomarkers (erythrocyte sedimentation rate, ESR, C-reactive protein, CRP) provide clues for diagnosis of piriformis pyomyositis. Some cases were very ill but no death was documented. Staphylococcus aureus was the most common pathogen, but Group A as well as Group β Streptococcus, Salmonella typhi, Proteus mirabilis, Brucella melitensis, and Escherichia coli were also involved in the disorder. To treat the piriformis pyomyositis, broad-spectrum antibiotics were found to be useful; however, sometimes, antibiotic switching was warranted based on blood and tissue aspirate reports. Drainage and/or surgical exploration of the affected piriformis muscle were required in cases where antibiotics appeared ineffective. Piriformis pyomyositis is a rara avis and performing of prospective studies will hardly be feasible.

KW - Myositis

KW - Piriformis pyomyositis

KW - Piriformis syndrome

KW - Staphylococcus aureus

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=85065420332&partnerID=8YFLogxK

U2 - 10.1007/s10067-019-04552-y

DO - 10.1007/s10067-019-04552-y

M3 - Review article

VL - 38

SP - 1811

EP - 1821

JO - Clinical rheumatology

JF - Clinical rheumatology

SN - 0770-3198

IS - 7

ER -